BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24549401)

  • 1. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
    Hashida N; Nakai K; Saitoh N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
    Zhou N; Xu X; Liu Y; Wang Y; Wei W
    Eye (Lond); 2022 Jul; 36(7):1448-1455. PubMed ID: 34211136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.
    Lam M; Touitou V; Choquet S; Cassoux N; Ghesquières H; Kodjikian L; Schmitt A; Gattoussi S; Tabouret É; Sampo M; Blonski M; Angioi-Duprez K; Houot R; Mouriaux F; Gyan E; Le Lez ML; Moles MP; Croisé F; Chauchet A; Schwartz C; Ahle G; Meyer L; Gressin R; Chiquet C; Oberic L; Ollé P; Marolleau JP; Jany B; Tempescul A; Cochener B; Damaj G; Quintyn JC; Moluçon-Chabrot C; Rousseau E; Franciane P; Schneider C; Massé H; Tamburini-Bonnefoy J; Brézin A; Fornecker LM; Ballonzoli L; Le Garff-Tavernier M; Hoang-Xuan K; Bodaghi B; Soussain C; Houillier C
    Am J Hematol; 2021 Jul; 96(7):823-833. PubMed ID: 33864703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate.
    Zhao H; Wang X; Mao Y; Peng X
    BMC Ophthalmol; 2020 Jan; 20(1):10. PubMed ID: 31906917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.
    Habot-Wilner Z; Frenkel S; Pe'er J
    Br J Haematol; 2021 Jul; 194(1):92-100. PubMed ID: 33900619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
    Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
    JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
    Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
    Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
    Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
    Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma.
    Anthony CL; Bavinger JC; Shantha JG; O'Keefe GD; Pearce WA; Voloschin A; Grossniklaus HE; Yeh S
    Int J Retina Vitreous; 2021 Dec; 7(1):72. PubMed ID: 34863313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma.
    Motomura Y; Yoshifuji K; Tachibana T; Takase H; Arai A; Tanaka K; Okada K; Nogami A; Umezawa Y; Sakashita C; Yamamoto M; Mori T; Nagao T
    Br J Haematol; 2024 Apr; 204(4):1279-1287. PubMed ID: 38131400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Vitreoretinal Lymphoma in HIV Infection.
    Steffen J; Coupland SE; Smith JR
    Ocul Immunol Inflamm; 2021 Apr; 29(3):621-627. PubMed ID: 32453669
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
    Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
    Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.
    Cheng CL; Yeh PT; Fang WQ; Ma WL; Hou HA; Tsai CH; Lin CP; Tien HF
    Cancer Med; 2023 Apr; 12(7):8102-8111. PubMed ID: 36602288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of Primary Vitreoretinal Lymphoma in an Indian Population.
    Mahajan S; Nijhawan R; Rajwanshi A; Karkhur S; Mulkutar S; Dogra M; Lal V; Gupta V; Gupta A
    Ocul Immunol Inflamm; 2017 Oct; 25(5):633-638. PubMed ID: 27003620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
    Chan CC; Rubenstein JL; Coupland SE; Davis JL; Harbour JW; Johnston PB; Cassoux N; Touitou V; Smith JR; Batchelor TT; Pulido JS
    Oncologist; 2011; 16(11):1589-99. PubMed ID: 22045784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary vitreoretinal lymphoma: a diagnostic and management challenge.
    Soussain C; Malaise D; Cassoux N
    Blood; 2021 Oct; 138(17):1519-1534. PubMed ID: 34036310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
    Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
    Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
    Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
    Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.